Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer
Running, not enrolling · Not applicable
Conditions studied: Head and Neck Carcinoma
In brief
This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedback training may help teach patients ways to modify their own brain waves to decrease the perception of pain and improve quality of life.
Key facts
- Study ID
- NCT02543320
- Run by
- M.D. Anderson Cancer Center
- People needed
- 17
- Starts
- 2012-08-29
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2026-04-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must have the ability to understand and read English, sign a written informed consent, and be willing to follow protocol requirements
- Patients must not have pain > 2 on a scale of 0 - 10 (self report) in the head and neck before starting radiotherapy
- Scheduled to undergo a 6 week course of radiotherapy for head and neck cancer
- No plans to change the type of pain medication during the course of the study
You may not qualify if…
- Patients who are taking any antipsychotic medications
- Patients with active central nervous system (CNS) disease, such as clinically-evident metastases or leptomeningeal disease, dementia, or encephalopathy
- Patients who have ever been diagnosed with bipolar disorder or schizophrenia
- Patients with known, previously diagnosed head or neck pain from other pain syndromes or chronic pain requiring analgesics
- Patients with a history of seizure disorders
Where it is running
- M D Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.